Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment.(Damman K, Perez AC, Anand IS, Komajda M, McKelvie RS, Zile MR, Massie B, Carson PE, McMurray JJ.) Renal P2 Receptors and Hypertension. (Menzies RI, Unwin RJ, Bailey MA.) The aging kidney revisited: a systematic review. (Bolignano D, Mattace-Raso F, Sijbrands EJ, Zoccali C.) Does a vitamin D boost help in resistant hypertension control? (Zoccali C, Mallamaci F.) A look at the upper heart chamber: the left atrium in chronic kidney disease.(Paoletti E, Zoccali C.) Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?(Liabeuf S, Okazaki H, Desjardins L, Fliser D, Goldsmith D, Covic A, Wiecek A, Ortiz A, Martinez-Castelao A, Lindholm B, Suleymanlar G, Mallamaci F, Zoccali C, London G, Massy ZA.) Statins for the prevention of contrast-induced acute kidney injury.(Ball T, McCullough PA.) Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography.(Ukaigwe A, Karmacharya P, Mahmood M, Pathak R, Aryal MR, Jalota L, Donato AA.) Acute kidney injury: Short-term statin therapy for prevention of contrast-induced AKI.(Mikhailidis DP, Athyros VG.) Focus on lipids: high-density lipoprotein cholesterol and its associated lipoproteins in cardiac and renal disease.(Shin HJ, McCullough PA.) Risk Factors for Heart Failure in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl.(Chin MP, Wrolstad D, Bakris GL, Chertow GM, de Zeeuw D, Goldsberry A, Linde PG, McCullough PA, McMurray JJ, Wittes J, Meyer CJ.) Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction.(Gori M, Senni M, Gupta DK, Charytan DM, Kraigher-Krainer E, Pieske B, Claggett B, Shah AM, Santos AB, Zile MR, Voors AA, McMurray JJ, Packer M, Bransford T, Lefkowitz M, Solomon SD; for the PARAMOUNT Investigators.) Ultrafiltration for the treatment of congestion: a window into the lung for a better caress to the heart.(Rossi GP, Calò LA, Maiolino G, Zoccali C.) Association of renal resistive index with aortic pulse wave velocity in hypertensive patients.(Geraci G, Mulè G, Geraci C, Mogavero M, D'Ignoto F, Morreale M, Foraci AC, Cottone S.) Mediation Analysis of Aortic Stiffness and Renal Microvascular Function.(Woodard T, Sigurdsson S, Gotal JD, Torjesen AA, Inker LA, Aspelund T, Eiriksdottir G, Gudnason V, Harris TB, Launer LJ, Levey AS, Mitchell GF.)

5° CARDIO VENICE. NUOVI APPROCCI MULTIDISCIPLINARI ALLO SCOMPENSO: GESTIONE CLINICA E SOSTENIBILE NEL 2017

Pubblicato il 20 Set, 2017

Logo_Sincar_Italia_positivo

“5° CARDIO VENICE. NUOVI APPROCCI MULTIDISCIPLINARI ALLO SCOMPENSO: GESTIONE CLINICA E SOSTENIBILE NEL 2017”

che si svolgerà dal 29 al 30 settembre 2017 presso l’Ospedale SS. Giovanni e Paolo (Venezia).

Desideriamo informarVi che l’iscrizione è GRATUITA per tutti gli iscritti ad SINCAR - Società Italiana di Nefrocardiologia

DOWNLOAD PROGRAMMA

DOWNLOAD SCHEDA DI ISCRIZIONE